Market Place
Sourcing Support
Teva, Sanofi say bowel disease drug met primary targets
18 Dec 2024 //
PRESS RELEASE
Teva Launches Patient Access Program for Uninsured Inhaler Access
11 Dec 2024 //
GLOBENEWSWIRE
Pharma firm Teva to divest its business venture in Japan
07 Dec 2024 //
REUTERS
Teva Launches Vital Medicines Program in El Salvador
27 Nov 2024 //
ACCESSWIRE
Teva to Present at 7th Annual Evercore ISI HealthCONx Conference
25 Nov 2024 //
GLOBENEWSWIRE
Teva Tackles Antimicrobial Resistance: Key Insights on AMR
20 Nov 2024 //
ACCESSWIRE
Teva to Present at the Jefferies London Healthcare Conference
08 Nov 2024 //
GLOBENEWSWIRE
Teva Pharma`s Generics Fedratinib Receives Tentative Approval in US
07 Nov 2024 //
FDA
Hefty sales of generics boost Teva to another big quarter
07 Nov 2024 //
FIERCE PHARMA
Teva Reports Strong Q3 2024 Results, Raises Financial Outlook
06 Nov 2024 //
GLOBENEWSWIRE
Teva Pharm CEO says will work productively with Trump
06 Nov 2024 //
REUTERS
Teva Pharmaceutical sees more growth in 2025 after strong Q3
06 Nov 2024 //
REUTERS
Teva Presents Schizophrenia Research, Phase 3 SOLARIS Trial Results
01 Nov 2024 //
GLOBENEWSWIRE
Teva Presents Tardive Dyskinesia Data at Psych Congress 2024
01 Nov 2024 //
GLOBENEWSWIRE
Teva Statement on European Commission Decision; Company to Appeal
31 Oct 2024 //
GLOBENEWSWIRE
Teva hit with €463M fine over Copaxone misconduct claims in EU
30 Oct 2024 //
FIERCE PHARMA
Neuroscience of Inclusion Unlocks High-Impact Team Performance
29 Oct 2024 //
ACCESSWIRE
Alvotech And Teva Announce FDA Approval Of SELARSDI™ Presentation
22 Oct 2024 //
GLOBENEWSWIRE
Fortrea Releases Inaugural Corporate Social Responsibility Report
17 Oct 2024 //
GLOBENEWSWIRE
Teva brings biotech ethos to drug development, exec says
15 Oct 2024 //
FIERCE BIOTECH
Teva to pay $450M to settle longstanding kickback allegations
14 Oct 2024 //
FIERCE PHARMA
Teva Prolia Biosimilar Accepted For Review By FDA And EMA
08 Oct 2024 //
GLOBENEWSWIRE
Teva Launches First Generic Version of Sandostatin® LAR Depot
01 Oct 2024 //
GLOBENEWSWIRE
Teva To Host Call On Q3 2024 Financial Results On November 6
30 Sep 2024 //
GLOBENEWSWIRE
Medincell Presents New Data On Olanzapine For Schizophrenia
23 Sep 2024 //
BUSINESSWIRE
Medincell`s Partner Teva Provides UZEDY Treatment Insights
23 Sep 2024 //
BUSINESSWIRE
New Data On Switching Schizophrenia Patients To UZEDY
21 Sep 2024 //
GLOBENEWSWIRE
Teva Presents TEV-`749 Phase 3 Data For Schizophrenia
21 Sep 2024 //
GLOBENEWSWIRE
Teva to Present at the Bank of America 2024 Global Healthcare Conference
11 Sep 2024 //
GLOBENEWSWIRE
Teva resolves Baltimore`s opioid litigation with $80M settlement
09 Sep 2024 //
FIERCE PHARMA
Opioid Plaintiffs Urge Court To Reject Fee Bid By Excluded Law Firms
09 Sep 2024 //
REUTERS
Medincell’s Partner Teva Updates on Phase 3 of Olanzapine Long-Acting Injectable
05 Sep 2024 //
BUSINESSWIRE
DEA Increases Production Limits on Takeda`s Vyvanse Amid Ongoing Shortages
05 Sep 2024 //
FIERCE PHARMA
NEUCA, Polpharma, Adamed, Teva, Zentiva Partner For ESG Development.
03 Sep 2024 //
PRESS RELEASE
Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
26 Aug 2024 //
GLOBENEWSWIRE
Teva Faces Fresh Copaxone Kickbacks Case From Medicare Providers
20 Aug 2024 //
FIERCE PHARMA
Teva rides growth momentum through Q2, boosts `24 sales outlook
31 Jul 2024 //
FIERCE PHARMA
Medincell`s Partner Teva Updates On Olanzapine LAI And UZEDY®
31 Jul 2024 //
BUSINESSWIRE
Teva Reports Strong Q2 Growth, Raises 2024 Guidance
31 Jul 2024 //
GLOBENEWSWIRE
Teva And Sanofi Accelerate Anti-TL1A Phase 2b Program For IBD
24 Jul 2024 //
BUSINESSWIRE
Enforcement Report - Week of July 24, 2024
24 Jul 2024 //
FDA
Teva touts first CGRP success in Phase III paediatric migraine prevention study
19 Jul 2024 //
BUSINESSWIRE
Teva To Host Q2 2024 Financial Results Call On July 31
02 Jul 2024 //
BUSINESSWIRE
FTC starts probe into Teva about some products` patents, Washington Post reports
01 Jul 2024 //
REUTERS
New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses
28 Jun 2024 //
BUSINESSWIRE
Enforcement Report - Week of June 26, 2024
26 Jun 2024 //
FDA
Teva settles tax dispute in Israel with $750 mln payment
25 Jun 2024 //
REUTERS
Teva resolves all pending tax litigation with Israel Tax Authority
25 Jun 2024 //
BUSINESSWIRE
Teva launches generic version of Novo Nordisk`s diabetes drug Victoza
25 Jun 2024 //
REUTERS
Teva sues Corcept over mifepristone `monopoly` for rare disorder
14 Jun 2024 //
REUTERS
Penn Medicine to expand collaboration on translational research in Abu Dhabi
12 Jun 2024 //
BIOSPECTRUM ASIA
Teva Pharms`s Generic Perampanel Receives Tentative Approval in US
04 Jun 2024 //
FDA
Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
04 Jun 2024 //
BUSINESSWIRE
New Data Provide Schizophrenia Insights On Switching To UZEDY
01 Jun 2024 //
BUSINESSWIRE
Teva`s IMPACT-TD Real-World Data On Tardive Dyskinesia At Psych Congress
01 Jun 2024 //
BUSINESSWIRE
Teva`s AUSTEDO® XR Approved As Once-Daily ADHD Treatment Option
29 May 2024 //
BUSINESSWIRE
Teva`s Adderall back in stock
23 May 2024 //
FIERCE PHARMA
Teva taps Shields to oversee manufacturing and supply division
16 May 2024 //
FIERCE PHARMA
Teva Appoints Matthew Shields As EVP Global Operations
15 May 2024 //
BUSINESSWIRE
